PharmAust CEO's sayanora triggers stock plunge
Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AWK | Ann: D&O Ongoing Disclosures - Multiple | 14/11/17 | 0 | 768 | |||
|
|||||||
AWK | Ann: SPH Notice, Hugh Ross Jones, HR Jones Family Trustees | 13/11/17 | 0 | 878 | |||
|
|||||||
AWK | Ann: SPH Notice - Rifa Jair Company Limited ("RIFA") | 13/11/17 | 0 | 833 | |||
|
|||||||
AWK | Ann: Payment by Rifa Jair Company Ltd | 10/11/17 | 0 | 771 | |||
|
|||||||
AWK | Ann: SPH Notice and Rule 49A Notice | 09/11/17 | 0 | 794 | |||
|
|||||||
AWK | Ann: Airwork Holdings Limited (“AWK”) – Delisting | 08/11/17 | 0 | 652 | |||
|
|||||||
AWK | Ann: Delisting of Airwork Holdings Ltd from NZX Main Board | 08/11/17 | 0 | 867 | |||
|
|||||||
AWK | Ann: SPH Notice and Rule 49A Notice | 06/11/17 | 0 | 669 | |||
|
See All Discussions